Virtual Presentations

Thyroid Nodule: Whack It, Zap It, or Leave It Alone?

Case Presenter: Sana Ghaznavi, MD
Moderator: Michael Tuttle, MD

Panelists:
Mary C Frates, MD
Marius N Stan, MD
Chienying Liu, MD
Julie Ann Sosa, MD, MA

Clinical Advances in Pituitary Diseases

Chair: Shlomo Melmed, MB ChB

• Osilodrostat Is an Effective and Well-Tolerated Treatment for Cushing's Disease (CD): Results From a Phase III Study With an Upfront, Randomized, Double-Blind, Placebo-Controlled Phase (LINC 4)
  Mônica Gadelha, MD, PhD
   
• Metyrapone Treatment in Endogenous Cushing’s Syndrome: Results at Week 12 From PROMPT, a Prospective International Multicenter, Open-Label, Phase III/IV Study
  Lynnette K Nieman, MD
   
• One-Year Outcomes of the Open-Label Extension of CHIASMA OPTIMAL, a Phase 3 Study of Oral Octreotide Capsules in Acromegaly
  Susan Leanne Samson, MD, PhD
   
• GLP1 Receptor Agonists Reduce Fluid Intake in Primary Polydipsia
  Bettina Felicitas Winzeler, MD

Transgender Care: A Comprehensive Assessment for a Multi-Faceted Condition

Chair: Stephen M Rosenthal, MD

• Psychosocial Assessment: A Key Component in the Care to Transgender Youth 89
  Thomas D Steensma, PhD
   
• Hormonal Management of Gender Dysphoria in Adolescents
  Sabine E Hannema, MD, PhD
   
• Transition of Care for Transgender Youth
  Vin Tangpricha, MD, PhD

Treatment Options in Osteoporosis Across the Spectrum of Fracture Risk

Chair: Elaine W Yu, MD

• Treatment Options for Individuals at Moderate Fracture Risk
  Ian Reid, FRACP
   
• Transitions in Osteoporosis Pharmacotherapy
  Benjamin Z Leder, MD
   
• Sclerostin Inhibition for the Treatment of Osteoporosis
  Suzanne M Jan De Beur, MD

How Do We Confront Disparities in Obesity and COVID-19 Treatment

Chair: Samuel Dagogo-Jack, MD, DSc

• Environmental Determinants that Contribute to Racial/Ethnic Disparities in Obesity-Related Metabolic Risk Factors
  Rebecca E Hasson, PhD
   
• Strategies for Reducing Obesity Disparities Through Policy
  Karen Glanz, PhD, MPH
   
• Race/Ethnicity, Obesity, and COVID-19
  Monica Webb Hooper, PhD

Obesity in Youth and Adolescent: Treatment of a Growing Problem

• Best Medical Practices in Obesity and Type 2 Diabetes Mellitus in Kids
  Seema Kumar, MD
   
• The Last Resort or a Definitive Treatment: Bariatric Surgery in Adolescents
  Thomas Inge, MD, PhD
   
• Pharmacotherapy for the Treatment of Adolescent Obesity: Where Are We Now? Where Are We Going?
  Ania M Jastreboff, MD, PhD